These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 13440686)

  • 1. [Effects butyl-sulfonyl urea on blood lipids in diabetics].
    CORSINI G; GUACCI L
    Minerva Med; 1957 Apr; 48(27):1119-24. PubMed ID: 13440686
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of intravenous & oral N-sulfanilyl-N-butyl urea (BZ 55) on blood sugar in diabetics and persons with normal metabolism].
    PFEFFER KH; FUCHS KJ; MICHEL W; FOERDER HK
    Arztl Wochensch; 1957 Mar; 12(12):260-3. PubMed ID: 13410706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrophoretic serous patterns (proteins, lipoproteins and glycoproteins) of diabetics during treatment with N-sulfanilyl-N'-butyl urea and N-tolyl-sulfonyl-N'-butyl urea].
    ZAMPA GA
    G Clin Med; 1957 Jan; 38(1):42-57. PubMed ID: 13448420
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood crasis, Mommsen granulations and leukocytic glycogen in diabetics treated with N'-sulfanilyl-N2-n-butyl urea].
    PELLEGRINI R; RUMPIANESI G
    Endocrinol Sci Cost; 1956; 23(4):272-8. PubMed ID: 13404963
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in glycemia and urea excretion in fasting diabetics treated with sulfanil-n-butyl urea].
    FEDELI S; MAGGI G; RIZZOLINI G
    Arch Sci Med (Torino); 1957 May; 103(5):361-7. PubMed ID: 13445444
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical data in diabetics treated with sulfanil-n-butyl urea].
    TAMBUSCIO S; FALETRA G
    Arch Sci Med (Torino); 1957 May; 103(5):355-60. PubMed ID: 13445443
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral management of diabetes mellitus with a sulfonyl-urea derivative, BZ 55].
    BERTRAM F
    Nord Med; 1956 Dec; 56(51):1834-7. PubMed ID: 13400309
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on peroral therapy of diabetes with a sulfonyl-urea derivative].
    HALLER H
    Z Gesamte Inn Med; 1957 Feb; 12(4):150-8. PubMed ID: 13434239
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in glycemia induced by sulfanil-n-butyl urea treatment of diabetes].
    FEDELI S; MAGGI G
    Arch Sci Med (Torino); 1957 May; 103(5):368-75. PubMed ID: 13445445
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypoglycemic coma in diabetics treated with sulfabutyl urea (BZ 55)].
    BUTTARO CA; TRAMONTANA C; GUAITINI V
    Riforma Med; 1957 Apr; 71(16):441-2. PubMed ID: 13442477
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new antidiabetic N-sulfanilyl-N'-butyl urea (BZ 55); preliminary results].
    CHAIA J
    Rev Med Moyen Orient; 1957; 14(1):47-50. PubMed ID: 13454198
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of inorganic phosphorus in blood after intravenous load of glucose in diabetics treated with butylsulfamidurea].
    GASTALDI F
    Arch Sci Med (Torino); 1957 May; 103(5):376-82. PubMed ID: 13445446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sulphanyl-butyl-urea in the treatment of diabetes mellitus].
    TIBERIO P
    Riforma Med; 1957 Jan; 71(3):64-8. PubMed ID: 13421383
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ambulant therapy of diabetics with hypoglycemic sulfonamide (BZ 55, nadisan, invenol)].
    HOFSTETTER JR; RAMEL C
    Helv Med Acta; 1956 Nov; 23(4-5):485-9. PubMed ID: 13398003
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical contribution to the study of antidiabetic effect of NI-sulfamilyl-N2-n-Butyl carbamide].
    LAURIA D; NICOLETTI MN; ASCIONE A
    Riforma Med; 1957 Jun; 71(25):697-8. PubMed ID: 13454517
    [No Abstract]   [Full Text] [Related]  

  • 17. Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period.
    KERLAN M
    J Tn State Med Assoc; 1957 Feb; 50(2):46-8. PubMed ID: 13399061
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy in diabetes mellitus with N-1-sulphanylil-N 2 n-butyl urea].
    GIORDANO G; PENDE G; ROMANO PM
    Arch Maragliano Patol Clin; 1956 Oct; 12(5):971-6. PubMed ID: 13395711
    [No Abstract]   [Full Text] [Related]  

  • 19. [Criteria for selection of diabetics to be treated with oral hypoglycemic drugs; test for sensitivity to sulfonylurea compounds].
    ARDUINO F
    Med Cir Farm; 1957 May; (253):187-98. PubMed ID: 13450825
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary excretion of acid mucopolysaccharides and mucoprotein in diabetics in basal conditions and after treatment with N-sulfanilyl-N'-butyl urea].
    GALLETTI F; PELLEGRINI R
    Arch Patol Clin Med; 1957; 33(3):153-64. PubMed ID: 13425840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.